Eris Lifesciences Limited has entered into an agreement to avail a term loan of ₹45,00,00,000/- (Rupees Forty Five Crores Only) from Axis Bank Limited. This financial adjustment is a routine measure to manage the company’s financial obligations and is not expected to impact the net debt figure at the end of the current quarter. The loan agreement was executed on September 09, 2026, with Axis Bank securing a charge on the company’s brands.
Term Loan Agreement with Axis Bank
Eris Lifesciences Limited has announced the execution of a term loan agreement with Axis Bank Limited, a transaction designed to bolster its financial resources. The company will avail a significant sum of ₹45,00,00,000/- (Rupees Forty Five Crores Only). This financial undertaking is characterized as a routine adjustment for managing the company’s overall financial structure.
Financial Impact and Security
While this term loan is a notable financial maneuver, Eris Lifesciences Limited has clarified that it is not anticipated to alter the expected Net Debt figure for the quarter’s conclusion. The agreement, officially executed on September 09, 2026, involves Axis Bank taking a charge on the company’s brands as security for the loan. The total amount of the term loan granted is ₹45,00,00,000/-.
Source: BSE
